K. Altundag Et Al. , "Selenium supplementation may increase the efficacy of cetuximab in metastatic colorectal cancer patients," MEDICAL HYPOTHESES , vol.64, no.6, pp.1162-1165, 2005
Altundag, K. Et Al. 2005. Selenium supplementation may increase the efficacy of cetuximab in metastatic colorectal cancer patients. MEDICAL HYPOTHESES , vol.64, no.6 , 1162-1165.
Altundag, K., Silay, Y., Altundag, O., Yigitbasi, O., Gundeslioglu, O., & Gunduz, M., (2005). Selenium supplementation may increase the efficacy of cetuximab in metastatic colorectal cancer patients. MEDICAL HYPOTHESES , vol.64, no.6, 1162-1165.
Altundag, K Et Al. "Selenium supplementation may increase the efficacy of cetuximab in metastatic colorectal cancer patients," MEDICAL HYPOTHESES , vol.64, no.6, 1162-1165, 2005
Altundag, K Et Al. "Selenium supplementation may increase the efficacy of cetuximab in metastatic colorectal cancer patients." MEDICAL HYPOTHESES , vol.64, no.6, pp.1162-1165, 2005
Altundag, K. Et Al. (2005) . "Selenium supplementation may increase the efficacy of cetuximab in metastatic colorectal cancer patients." MEDICAL HYPOTHESES , vol.64, no.6, pp.1162-1165.
@article{article, author={K Altundag Et Al. }, title={Selenium supplementation may increase the efficacy of cetuximab in metastatic colorectal cancer patients}, journal={MEDICAL HYPOTHESES}, year=2005, pages={1162-1165} }